RUQ US and CT were performed showing bile duct dilation to over 2 cm with the presence of stones, sludge and debris.
Labs were significant for WBC 17, T bili 16.7, Alk phos 234, ast/alt 112/150, cr 0.7.
In the ED initial vital signs were, T 98.9 BP 120/86 HR 170 RR 20 SpO2 98%.
She was found to be in atrial fibrillation with rates reaching 180s.
With addition of small metoprolol boluses of 5 mg IV x 3 her heart rate was in 120s to 130s.
Physical Exam: Physical Exam on Arrival to [**Hospital Unit Name 2112**]: Temp: 99.4 BP: 119/65 HR: 140 RR: 21 O2sat 95% RA GEN: pleasant, jaundiced, drowsy comfortable, NAD HEENT: PERRL, disconjugate gaze, icteric, very dry MM, op without lesions, no supraclavicular or cervical lymphadenopathy, JVD difficult to assess RESP: poor inspiratory effort, good air movement throughout CV: distant heart sounds, tachycardic, irregular, no m/r/g ABD: obese, no ascites, nd, +b/s, soft, nt EXT: no c/c/e , 2+ distal pulses SKIN: diffusely juandiced, no rashes NEURO: awake but drowsy, oriented to person x 2.
Pertinent Results: [**2185-11-8**] 12:19PM BLOOD WBC-14.7* RBC-4.18* Hgb-13.0 Hct-36.3 MCV-87 MCH-31.0 MCHC-35.8* RDW-14.0 Plt Ct-177 [**2185-11-8**] 12:19PM BLOOD Neuts-84* Bands-0 Lymphs-11* Monos-4 Eos-0 Baso-0 Atyps-0 Metas-1* Myelos-0 [**2185-11-8**] 12:19PM BLOOD PT-13.2 PTT-19.5* INR(PT)-1.1 [**2185-11-8**] 12:19PM BLOOD Glucose-137* UreaN-24* Creat-0.8 Na-151* K-3.7 Cl-118* HCO3-24 AnGap-13 [**2185-11-8**] 12:19PM BLOOD ALT-137* AST-105* AlkPhos-233* TotBili-17.4* DirBili-15.0* IndBili-2.4 [**2185-11-8**] 12:19PM BLOOD Lipase-40 [**2185-11-8**] 12:19PM BLOOD Calcium-9.2 Phos-1.5* Mg-2.3 [**2185-11-8**] 12:19PM BLOOD TSH-2.3 [**2185-11-8**] 09:36PM URINE Color-Brown Appear-Clear Sp [**Last Name (un) **]-1.019 [**2185-11-8**] 09:36PM URINE Blood-SM  Nitrite-NEG Protein-TR Glucose-NEG Ketone-NEG Bilirub-LG Urobiln-NEG pH-5.5 Leuks-SM [**2185-11-8**] 09:36PM URINE RBC-2 WBC-11* Bacteri-FEW Yeast-NONE Epi-<1 [**2185-11-8**] 09:36PM URINE Mucous-RARE  ================= MICROBIOLOGY ================= [**2185-11-8**] - MRSA screen:------ - Urine cx: negative  ================= IMAGING ================= [**2185-11-8**] - CXR: A single semi-upright portable view of the chest was obtained.
Right hilar prominence is noted without other findings of overt edema, which may represent vascular crowding versus central vascular congestion.
A physical exam was performed.
The patient was placed in the prone position and an endoscope was introduced through the mouth and advanced under direct visualization until the third part of the duodenum was reached.
Findings: Esophagus: Limited exam of the esophagus was normal Stomach: Limited exam of the stomach was normal Duodenum: Limited exam of the duodenum was normal Major Papilla: There was pus discharge at the major papilla.
Contrast medium was injected resulting in partial opacification.
Repeat ERCP in [**1-19**] weeks for stent removal and sphincterotomy/sphincteroplasty with stone extraction.
Discharge labs: COMPLETE BLOOD COUNT WBC RBC Hgb Hct MCV MCH MCHC RDW Plt Ct [**2185-11-10**] 03:01    9.7 3.37* 10.1* 30.5* 90 29.9 33.1 15.0 149*  RENAL & GLUCOSE Glucose UreaN Creat Na K Cl HCO3 AnGap [**2185-11-10**] 03:01    [**Telephone/Fax (2) 87671**]* 3.4 116* 25 9 ENZYMES & BILIRUBIN ALT AST LD(LDH) CK(CPK) AlkPhos Amylase TotBili DirBili IndBili [**2185-11-10**] 03:01    85* 56*     199*   9.2*   Brief Hospital Course: A/P:  73 year old woman with h/o HTN presents to OSH with AMS and jaundice found to have choledocholithiasis and UTI.
#  Obstructive jaundice:  RUQ Ultrasound and CT confirm choledocholithiasis.
Pain was well controlled, and patient was afebrile throughout her hospital stay, and she was hemodynamically stable.
She will need a repeat ERCP for sphincterotomy and stent removal - Please continue IV Zosyn - Please convert oral regiment to Augmentin or Cipro/Metronidazole (depending on UTI) .
A urine culture was taken which shows no growth.
- Continue Zosyn empirically - Check sensitivities since patient has history of multiple UTI's .
Piperacillin-Tazobactam 4.5 g IV Q8H 2.
